Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.

Wijnands, M J; Allebes, W A; Boerbooms, A M; van de Putte, L B; van Riel, P L

Wijnands, M J; Allebes, W A; Boerbooms, A M; van de Putte, L B; van Riel, P L.

Affiliation

Wijnands MJ; University Hospital, Nijmegen, The Netherlands.

Ann Rheum Dis ; 49(10): 798-800, 1990 Oct.

Article in En | MEDLINE | ID: mdl-1978639

Subject(s)

Aurothioglucose/adverse effects; Hydroxychloroquine/adverse effects; Sulfasalazine/adverse effects; Thrombocytopenia/chemically induced; Arthritis, Rheumatoid/drug therapy; Female; HLA-B8 Antigen/analysis; HLA-DR3 Antigen/analysis; Humans; Immunoglobulin G/analysis; Immunoglobulin M/analysis; Middle Aged; Thrombocytopenia/genetics; Thrombocytopenia/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfasalazine / Thrombocytopenia / Aurothioglucose / Hydroxychloroquine Limits: Female / Humans / Middle aged Language: En Journal: Ann Rheum Dis Year: 1990 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google